Old Mission Capital LLC Zynerba Pharmaceuticals, Inc. Transaction History

Old Mission Capital LLC

  • $4.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$0.5 - $0.72 $500 - $720
1,000 New
1,000 $0
Q3 2020

Nov 16, 2020
SELL
$3.23 - $4.3 $200,906 - $267,460
-62,200 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$3.31 - $6.54 $205,882 - $406,788
62,200 New
62,200 $210,000

Others Institutions Holding ZYNE

# of Institutions
4
Shares Held
774K
Call Options Held
0
Put Options Held
0
View Full List

About Zynerba Pharmaceuticals, Inc.

ZYNE Quotes by TradingView
  • Ticker ZYNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,753,100
  • Description
  • Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...
More about ZYNE
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email